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Although folic acid has been investigated for its potential to inhibit carcinogenesis, few epidemiologic studies have assessed the effects
of intake of thiamin, riboflavin, and niacin, which may reduce cancer risk by acting as cofactors in folate metabolism or by other
mechanisms. Using data from a large cohort of Canadian women, we examined the association of dietary intake of these nutrients, as
well as intake of folate, methionine, and alcohol, with cancers of the breast, endometrium, ovary, colorectum, and lung ascertained
during an average of 16.4 years of follow-up. After exclusions, the following numbers of incident cases were available for analysis:
breast, n¼2491; endometrium, n¼426; ovary, n¼264; colorectum, n¼617; and lung, n¼358. Cox proportional hazard models
were used to estimate risk of each cancer with individual nutrients and to explore possible effect modification by combinations of
nutrients on cancer risk. Few significant associations of intake of individual B vitamins with the five cancers were observed. Alcohol
consumption showed a modest positive association with breast cancer risk but not with risk of the other cancers. There was no
evidence of effect modification among the nutrients. This large study provides little support for an association of dietary intake
thiamin, riboflavin, niacin, folate, or methionine with five major cancers in women.
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Interest in the potential of folate to reduce the risk of common
cancers stems from the important role of this B vitamin in one-
carbon metabolism. Optimal one-carbon metabolism is necessary
for the synthesis of the purines, adenine and guanine, and the
conversion of uridylate to thymidylate, which blocks the
misincorporation of uracil into DNA (Choi and Mason, 2000;
Ziegler and Lim, 2007). Dysregulation of one-carbon metabolism
and DNA methylation is believed to promote carcinogenesis (Kim,
2004). Other B vitamins, including thiamin (vitamin B1), riboflavin
(vitamin B2), and niacin (vitamin B3) may also play a role in
carcinogenesis, either by acting as cofactors in folate metabolism
(riboflavin (Powers, 2003, 2005)) or by their independent roles in
DNA synthesis (thiamin (Boros, 2000)), maintaining genomic
stability, DNA repair, and regulation of cell division and apoptosis
(niacin (Jacobson et al, 1995; Ames, 2001; Kirkland, 2003)).
Epidemiological evidence regarding the association of folate and
cancer of various sites has been inconsistent (Lewis et al, 2006;
Larsson et al, 2007; Ziegler and Lim, 2007). Furthermore, few
studies have assessed the roles of thiamin, riboflavin, or niacin in
relation to the risk of commonly occurring cancers (Jedrychowski
et al, 2002; van den Donk et al, 2005; Xu et al, 2007).
Given the conflicting data on folate and the paucity of studies on
the other related nutrients, we examined the associations between
dietary intake of folate, thiamin, riboflavin, and niacin and risk of
cancers of the breast, endometrium, ovary, colorectum, and lung
in the National Breast Screening Study (NBSS), a large cohort of
Canadian women. In addition, we assessed the effects of intake of
methionine, in view of its role as a methyl donor, and of alcohol
intake, as alcohol is a known folate antagonist and may increase
the requirement for folate and possibly other B vitamins
(Giovannucci, 2004; Po ¨schl et al, 2004). Previous reports using
the NBSS have examined the association of folate, methionine, and
alcohol intake in the development of breast and colorectal cancer
(Rohan et al, 2000; Terry et al, 2002a) and of folate and alcohol
intake in relation to endometrial cancer (Jain et al, 2000b). The
present study updates these earlier analyses with an additional 6
years of follow-up as well as presenting results on thiamin,
riboflavin, and niacin. The five cancer sites were selected because
they are among the most common cancers in women, accounting
for approximately 61% of all cancers in women (Jemal et al, 2008).
MATERIALS AND METHODS
Study population and questionnaire
The Canadian National Breast Screening Study is a randomised
controlled trial of screening for breast cancer, which has been
described in detail elsewhere (Miller et al, 1992; Terry et al, 2002b).
In brief, 89835 women aged 40–59 were recruited from the general
Canadian population between 1980 and 1985. On enrollment into
the study, information was obtained from participants on
demographic, hormonal, and reproductive characteristics using a
self-administered lifestyle questionnaire. Starting in 1982, a self-
administered food frequency questionnaire (FFQ) developed for
the NBSS (Jain et al, 1982) was distributed to all new attendees at
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centres for re-screening. A total of 49654 dietary questionnaires
were returned and were available for analysis. Use of the self-
administered questionnaire was validated by comparison with an
interviewer-administered version of the same questionnaire (Jain
et al, 1982). The FFQ elicited information on usual portion size and
consumption of 86 food items, including alcoholic beverages, and
included photographs of portion sizes to assist respondents in
quantifying intake. Responses were used to estimate the daily
intake of calories, alcohol, and selected nutrients with the use of a
nutrient database developed by modifying the US Department of
Agriculture’s food composition tables to include typically Cana-
dian foods (Jain et al, 1996). The estimates of nutrient intake that
are the focus of this report were derived from dietary sources
alone.
Ascertainment of index cancers and deaths
Incident cases of breast, endometrial, ovarian, colorectal, and lung
cancer and deaths from all causes were ascertained respectively by
means of computerised record linkages to the Canadian Cancer
Database and to the National Mortality Database. The linkages to
the databases yielded data on cancer incidence and mortality to 31
December 2000 for women in Ontario, 31 December 1998 for
women in Quebec, and 31 December 1999 for women in other
provinces. For the present analyses, study participants were
considered at risk from their date of enrollment until the date of
diagnosis of their breast, endometrial, ovarian, colorectal, or lung
cancer, termination of follow-up (the date to which cancer
incidence data were available for women in the corresponding
province) or death, whichever occurred first. After exclusions,
during an average of 16.4 years (786588 person-years) of follow-up
of the dietary cohort, the following numbers of incident cases were
available for analysis: breast, n¼2491; endometrium, n¼426;
ovary, n¼264; colorectum, n¼617; and lung, n¼358.
Statistical analysis
Separate analyses were carried out for each cancer site. For
analyses of endometrial cancer, 14906 women who had had a
hysterectomy were excluded (67 cases and 14839 noncases). For
analysis of ovarian cancer, 318 women who reported a bilateral
oopherectomy were excluded (three cases and 315 noncases). In
addition, for all analyses, women whose calorie intake was o730
or 45389kcalday
 1 (i.e., more than three s.d. from the mean of
the log-transformed values) or whose body mass index (BMI) was
o15 or 450kgm
 2 were excluded.
Cox proportional hazard models were used to estimate hazard
ratios (HR) and 95% confidence intervals (CI) for the association
between intake of B vitamins, methionine, and alcohol, and cancer
risk. All dietary variables were adjusted for total energy intake,
using the residuals method (Willett and Stampfer, 1986). For these
analyses, the B vitamins of interest and methionine were
categorised by quintiles based on their distribution in the total
population. For alcohol, intake was categorised as nondrinker, 40
to o5, 5 to o10, 10 to o20, 20 to o30, 30þ gday
 1. Variables
were included in the multivariate models if they were established
risk factors for a given cancer or if their inclusion in the model
changed the parameter estimate for the nutrients of interest by
more than 10%. The covariates included in the main models for
the five cancers are listed in the footnotes to Table 2. Addition of
indicator variables for screening centre and randomisation group
in the original clinical trial (intervention/usual care) did not affect
the risk estimates, and therefore these variables were omitted. To
test for trends in risk with increasing levels of an exposure of
interest, we assigned the median value for each quintile of that
exposure variable and then fitted the medians as a continuous
variable in the risk models. We then evaluated the statistical
significance of the corresponding coefficient using the Wald test
(Rothman and Greenland, 1998). As early symptoms of the disease
might result in dietary change, we repeated the analyses for the five
cancer sites, excluding cases diagnosed during the first 5 years of
follow-up.
We further examined potential effect modification between
nutrients by creating combined variables for each combination of
two nutrients categorised into tertiles relative to the reference
group containing women in the lowest tertile of both nutrients
(HR¼1.0). For example, women with low folate/moderate
thiamine, moderate folate/moderate thiamin, high folate/moderate
thiamin, and so on, were compared with women with low folate/low
thiamin. Cutpoints for tertiles were: alcohol (nondrinker;
40 but o6.6gday
 1 (the median intake among drinkers),
X6.6gday
 1); folate (o267, 267–334, X334mgday
 1);
thiamin (o1.15, 1.15 to o1.33, X1.33mgday
 1); riboflavin
(o1.56, 1.56 to o1.93, X1.93mgday
 1); niacin (o18.1, 18.1 to
o21.0, X21.0mgday
 1); and methionine (o1.92, 1.92 to o2.26,
X2.26gday
 1). We examined the statistical significance of the HRs
in the resulting 3 3 tables. Tests for interaction were based on the
likelihood ratio tests comparing models with and without the
product terms representing the variables of interest as continuous
variables. The likelihood ratio test that all of the interaction
parameters were 0 was performed by referring 2* the absolute
difference in the log likelihoods of the models with and without the
interaction terms to the w
2 distribution with 1 degree of freedom.
All statistical significance tests were two-sided. All analyses were
performed using SAS version 9 (SAS Institute Cary, NC, USA).
RESULTS
Correlations between the B vitamins, methionine, and alcohol are
shown in Table 1. Intakes of niacin and methionine showed the
strongest correlation (r¼0.56), followed by folate and thiamin
(r¼0.49), riboflavin and methionine (r¼0.47), and intake of
folate and riboflavin (n¼0.43). Intakes of B vitamins and
methionine were inversely but weakly correlated with alcohol
consumption.
Breast cancer
None of the B vitamins or methionine was associated with risk of
breast cancer, whereas alcohol intake showed a weak, borderline
positive association: the HR for those consuming 30þ g of alcohol
per day was 1.17, 95% CI 0.98–1.39 (Table 2). Results were similar
in analyses stratified by menopausal status (premenopausal,
postmenopausal) and were not affected by exclusion of cases
diagnosed during the first 5 years of follow-up (data not shown).
There was no evidence of effect modification when combinations
of nutrients and alcohol were considered, and none of the formal
tests for interaction was statistically significant.
Table 1 Pearson correlation coefficients for intake of B vitamins and
other factors among 49654 women in the NBSS
a
Folate Thiamine Riboflavin Niacin Methionine
Folate
Thiamin 0.49
Riboflavin 0.43 0.32
Niacin 0.20 0.27 0.13
Methionine 0.12 0.18 0.47 0.56
Alcohol  0.05  0.18  0.13  0.15  0.15
aAll correlations are significant at Po0.0001.
B vitamins and risk of major cancers in women
GC Kabat et al
817
British Journal of Cancer (2008) 99(5), 816–821 & 2008 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yEndometrial cancer
None of the B vitamins, methionine, or alcohol was associated
with risk of endometrial cancer (Table 2). The results were not
affected by excluding cases diagnosed during the first 5 years
of follow-up. There were no significant interactions between
nutrients or between nutrients and alcohol and endometrial
cancer risk.
Table 2 Multivariable-adjusted hazard ratios and 95% confidence intervals for the association of dietary intake of B-vitamins and other factors with risk of
breast, endometrial, ovarian, colorectal, and lung cancer in the NBSS
Characteristic
quintiles
Breast cancer
(n cases¼2491)
HR
a (95% CI)
Endometrial
cancer
(n cases¼426)
HR
b (95% CI)
Ovarian cancer
(n¼264)
HR
c (95% CI)
Colorectal
cancer
(n cases¼617)
HR
d (95% CI)
Lung cancer
quintiles
(n¼358)
HR
e (95% CI)
Folate (mgday
 1)
o237 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
237 to o281 0.99 (0.87–1.13) 0.91 (0.65–1.26) 1.13 (0.78–1.64) 0.99 (0.76–1.29) 0.81 (0.59–1.11)
281 to o321 1.03 (0.91–1.17) 1.07 (0.78–1.48) 0.91 (0.62–1.35) 1.09 (0.84–1.41) 0.64 (0.45–0.91)
321 to o374 0.98 (0.86–1.12) 1.12 (0.81–1.54) 1.09 (0.74–1.59) 1.12 (0.86–1.44) 0.93 (0.67–1.28)
374+ 1.02 (0.90–1.17) 0.79 (0.55–1.13) 1.05 (0.71–1.54) 0.89 (0.68–1.17) 1.12 (0.83–1.52)
P trend 0.79 0.55 0.92 0.74 0.43
Thiamin (mgday
 1)
o1.06 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
1.06 to o1.19 1.08 (0.95–1.23) 1.34 (0.96–1.86) 0.91 (0.63–1.31) 1.06 (0.82–1.36) 0.96 (0.69–1.32)
1.19 to o1.30 1.11 (0.98–1.27) 1.19 (0.85–1.68) 0.83 (0.57–1.21) 1.12 (0.87–1.45) 1.03 (0.75–1.42)
1.30 to o1.43 1.05 (0.93–1.20) 1.26 (0.90–1.77) 0.88 (0.61–1.28) 0.90 (0.69–1.17) 1.13 (0.82–1.56)
1.43+ 1.04 (0.91–1.18) 1.27 (0.90–1.78) 0.78 (0.53–1.15) 0.82 (0.62–1.08) 0.99 (0.71–1.38)
P trend 0.79 0.35 0.22 0.07 0.69
Riboflavin (mgday
 1)
o1.41 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
1.41 to o1.63 0.98 (0.86–1.11) 0.86 (0.61–1.21) 0.83 (0.57–1.20) 1.03 (0.80–1.33) 1.06 (0.76–1.46)
1.63 to o1.86 0.96 (0.84–1.09) 0.94 (0.68–1.32) 0.90 (0.63–1.30) 0.99 (0.77–1.28) 1.08 (0.77–1.51)
1.86 to o2.17 0.98 (0.87–1.12) 0.79 (0.55–1.13) 0.95 (0.66–1.36) 0.85 (0.65–1.11) 1.20 (0.86–1.67)
2.17+ 0.99 (0.87–1.12) 0.78 (0.52–1.17) 0.57 (0.37–0.86) 0.94 (0.73–1.23) 1.30 (0.94–1.80)
P trend 0.89 0.22 0.05 0.31 0.08
Niacin (mgday
 1)
o16.9 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
16.9 to o18.7 0.96 (0.84–1.09) 1.08 (0.79–1.47) 1.09 (0.75–1.58) 1.08 (0.84–1.39) 1.14 (0.80–1.62)
18.7 to o20.5 0.98 (0.86–1.11) 1.05 (0.77–1.44) 0.89 (0.60–1.32) 1.08 (0.85–1.39) 0.95 (0.66–1.35)
20.5 to o22.8 0.97 (0.85–1.10) 0.93 (0.67–1.28) 1.05 (0.72–1.53) 0.97 (0.75–1.25) 1.03 (0.72–1.45)
22.8+ 0.97 (0.85–1.10) 0.90 (0.64–1.26) 0.98 (0.66–1.45) 0.95 (0.74–1.23) 1.19 (0.86–1.65)
P trend 0.74 0.35 0.87 0.43 0.43
Methionine (gday
 1)
o1.78 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
1.78 to o2.00 1.04 (0.92–1.19) 0.90 (0.64–1.25) 1.05 (0.73–1.51) 0.99 (0.77–1.28) 0.80 (0.58–1.10)
2.00 to o2.20 1.08 (0.95–1.22) 1.04 (0.76–1.43) 0.80 (0.55–1.17) 0.91 (0.71–1.18) 0.73 (0.52–1.03)
2.20 to o2.48 0.98 (0.86–1.12) 0.93 (0.67–1.28) 0.94 (0.64–1.37) 0.92 (0.71–1.20) 1.05 (0.77–1.42)
2.48+ 1.00 (0.88–1.14) 0.77 (0.54–1.08) 0.89 (0.61–1.31) 0.99 (0.76–1.28) 0.95 (0.69–1.31)
P trend 0.68 0.20 0.42 0.73 0.76
Alcohol
Nondrinker 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
40t oo5gday
 1 1.00 (0.90–1.12) 1.15 (0.88–1.51) 0.90 (0.63–1.29) 0.92 (0.73–1.14) 0.94 (0.69–1.27)
5t oo10gday
 1 0.98 (0.86–1.13) 1.00 (0.71–1.41) 1.33 (0.89–1.96) 0.93 (0.71–1.22) 0.77 (0.52–1.13)
10 to o20gday
 1 1.07 (0.93–1.23) 1.21 (0.86–1.68) 0.85 (0.54–1.32) 1.04 (0.79–1.36) 0.76 (0.53–1.11)
20 to o30gday
 1 1.08 (0.89–1.32) 1.34 (0.85–2.12) 1.50 (0.88–2.56) 1.13 (0.77–1.64) 0.81 (0.49–1.34)
30+ 1.17 (0.98–1.39) 0.84 (0.52–1.36) 1.23 (0.74–2.04) 1.02 (0.72–1.44) 1.03 (0.71–1.51)
P trend 0.06 0.04 0.22 0.48 0.12
aAdjusted for age (continuous), body mass index (kg/m
2 – continuous), pack-years of smoking (none, 40t oo10, 10 to o20, 20 to o30, 30+), years of education (three
levels), menopausal status (pre-, peri-, post), family history of breast cancer (no, yes), history of breast biopsy (no, yes), age at menarche (o12, 12, 13, 413), parity (continuous),
oral contraceptive use (never, ever), hormone replacement therapy (never, ever), and intake of calories (continuous). In addition, all nutrients except alcohol were adjusted for
alcohol intake (continuous).
bAdjusted for age (continuous), body mass index (kg/m
2 – continuous), years of education (three levels), menopausal status (pre-, peri-, post), parity
(continuous), age at menarche (o12, 12, 13, 413), oral contraceptive use (ever, never), hormone replacement therapy (never, ever), and intake of calories, calcium, and raw
vegetables (all continuous). In addition, all nutrients except alcohol were adjusted for alcohol intake (continuous).
cAdjusted for age (continuous), body mass index (kg/m
2 –
continuous), years of education (three levels), menopausal status (pre-, peri-, post), parity (continuous), duration of oral contraceptive use (4 levels), duration of hormone
replacement use (4 levels), hysterectomy (yes/no).
dAdjusted for age (continuous), body mass index (kg/m
2 – continuous), pack-years of smoking (none, 40t oo10, 10 to o20,
20 to o30, 30+), years of education (3 levels), menopausal status (pre-, peri-, post), oral contraceptive use (never, ever), hormone replacement therapy (never, ever), and intake
of calories (continuous). In addition, all nutrients except alcohol were adjusted for alcohol intake (continuous).
eAdjusted for age (continuous), body mass index (kg/m
2 –
continuous), years of education (three levels), parous/nulliparous, smoking status, pack-years of smoking (Never, 1–9, 10–19, 20–29, 30–39, 40+), and alcohol (continuous).
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The highest quintile of riboflavin intake was associated with
reduced risk: HR 0.57, 95% CI 0.37–0.86, P¼0.05 (Table 2). The
association was unchanged when cases diagnosed during the first 5
years of follow-up were excluded. There were no other significant
associations with ovarian cancer and no interactions between
nutrients and ovarian cancer.
Colorectal cancer
The B vitamins, methionine, and alcohol were not associated with
colorectal cancer risk (Table 2) or with subsites within the
colorectum (proximal colon, distal colon, and rectum) (data not
shown). When cases diagnosed during the first 5 years of follow-up
were excluded, thiamin intake showed an inverse association with
colorectal cancer risk (HR for highest vs lowest quintile 0.78, 95%
CI 0.59–1.04, P for trend 0.02). There were no significant
interactions between nutrients, or between nutrients and alcohol
intake, and colorectal cancer risk.
Lung cancer
Riboflavin intake showed a borderline positive association with
lung cancer risk: HR for highest quintile of intake 1.30, 95% CI
0.94–1.80, P¼0.08 (Table 2). When cases diagnosed during the
first 5 years of follow-up were excluded, the HR was 1.38, 95% CI
0.98–1.94, P¼0.04. There were no interactions between different
nutrients and lung cancer risk.
DISCUSSION
Results from this large cohort of women followed for an average of
16 years provide little support for an association of folate, thiamin,
riboflavin, niacin, or methionine and risk of five major cancers in
women. Alcohol consumption showed a weak positive association
with breast cancer but not with any of the other cancer sites. There
was no suggestion of an interaction between alcohol consumption
and intake of individual micronutrients or between any of the
micronutrients with each other in relation to risk of cancer at the
five anatomic sites.
Our null findings regarding folate and breast cancer are in
agreement with the results of two recent meta-analyses (Lewis
et al, 2006; Larsson et al, 2007), as well as with results from an
earlier analysis of the NBSS (Rohan et al, 2000), and our results
concerning folate and endometrial cancer are in agreement with
those of a previous report from the NBSS cohort (Jain et al, 2000a).
A recent meta-analysis of the relationship between folate intake
and colorectal cancer risk (Sanjoaquin et al, 2005) showed a
modest inverse association with dietary intake (RR for high vs low
intake 0.75, 95% CI 0.64–0.89) but not with total folate intake (RR
0.95, 95% CI 0.81–1.11); however, a large study of folate intake and
colorectal adenoma (Flood et al, 2002) found no association.
Results of cohort studies of the association between folate and
ovarian cancer are inconsistent (Kelemen et al, 2004; Larsson et al,
2004; Tworoger et al, 2006). Our results for lung cancer are
consistent with those from a pooled analysis of eight prospective
studies (Cho et al, 2006) but contrast with those of a cohort study
from the Netherlands (Voorrips et al, 2000) showing an inverse
association between folate intake and lung cancer, which was
strongest in current smokers.
Findings regarding the association of methionine with cancers
of the breast, endometrium, and ovary have generally been null
(Thorand et al, 1998; Shrubsole et al, 2001; Feigelson et al, 2003;
Tworoger et al, 2006; Xu et al, 2007; Cho et al, 2007a), whereas for
colorectal cancer, the findings have been mixed, with
some suggesting an inverse association (Giovannucci et al,
1993, 1995, 1998) and others showing no association (Ferraroni
et al, 1994; Slattery et al, 1997; Flood et al, 2002; Harnack
et al, 2002). We are unaware of any previous studies that
have examined the association of methionine intake and lung
cancer risk.
Few studies have examined the association of thiamin,
riboflavin, or niacin with common epithelial cancers. One small
case–control study of colorectal cancer (Jedrychowski et al, 2002)
observed a significant inverse association with dietary thiamin
intake but not with riboflavin intake. A second case–control study
(Ferraroni et al, 1994) reported a significant inverse association of
thiamin intake with colon cancer risk in both males and females,
but found no association with niacin or folate intake. In a large
case–control study from China (Xu et al, 2007), intake of
riboflavin was not associated with endometrial cancer risk. To
our knowledge, no cohort studies have reported on the association
of thiamin, riboflavin, or niacin with any of the cancers addressed
here.
Our findings of a significant inverse association for the highest
vs the lowest quintile of riboflavin intake with ovarian cancer, a
borderline inverse association of thiamin intake with colorectal
cancer, and a borderline positive association of riboflavin intake
with lung cancer risk should be interpreted cautiously, considering
the modest nature of these associations and the large number of
comparisons.
In all dietary studies focusing on individual nutrients,
there is the potential for confounding due to the fact that many
nutrients are correlated (either positively or inversely)
with each other (Key, 1994; Bingham, 2006). Furthermore, the
levels and activity of one nutrient may be affected by those
of other nutrients in the same pathway or interacting
pathways. One-carbon metabolism may involve as many as 25
enzymes, some of which require the presence of vitamin B-6,
vitamin B-12, and riboflavin, in addition to folate, as coenzymes
(Ziegler and Lim, 2007). Availability of these nutrients is
influenced by diet, use of supplements, alcohol consumption,
and genetic polymorphisms that play a role in the metabolism of
folate and other B vitamins. Furthermore, there is
suggestive evidence that, depending on the dose and timing of
administration, supplemental folate may have adverse effects
on colorectal and ovarian cancer risk (Kelemen et al, 2004;
Cole et al, 2007; Ziegler and Lim, 2007). In view of this complexity
and the problems of using estimates of intake of individual
nutrients obtained at one point in time, the potential role of B
vitamins in providing protection against common cancers remains
unresolved.
Strengths of the present study include large numbers of the five
cancers, the high level of completeness of follow-up of the cohort,
and the availability of baseline information on a wide range of
lifestyle exposures. In the case of breast cancer particularly, the
large sample size afforded good statistical power to detect
associations in subgroups and interactions. Limitations include
the fact that we only had exposure information obtained at
baseline and that dietary patterns, and hence intake of specific
nutrients, may have changed over the long follow-up period,
leading to misclassification of exposure and reduced
power to detect associations. Another limitation is that the FFQ,
with 86 food items, may have omitted foods that make a
substantial contribution to the nutrients that we focused
on. Furthermore, information on use of these vitamins as
supplements was not obtained in this study. Finally, intake of
other vitamins and nutrients, such as vitamin B-6, vitamin B-12,
choline, and betaine, which play a role in one-carbon metabolism
and may influence cancer risk (Ziegler and Lim, 2007; Cho
et al, 2007b; Xu et al, 2008), was not computed in the NBSS
nutrient data base.
In conclusion, the present study provides little evidence
for associations between dietary intake of folate, thiamin,
riboflavin, niacin, or methionine and risk of cancers of
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given the potential role of these vitamins and nutrients in
carcinogenesis and particularly given the paucity of studies
to date regarding intake of thiamin, riboflavin, and niacin
and the risk of epithelial cancers, further investigations are
warranted.
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